ArticlePloS one2020

Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study.

Myungsun Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.